ArticleSystematic reviews2024
End-of-life care for people with chronic obstructive pulmonary disease: a scoping review protocol.
Article in Systematic reviews, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChronic obstructive pulmonary disease (COPD) is a progressive inflammatory disease that has a typical illness trajectory. Awareness of unique disease courses as well as providing end-of-life care (EOLC) for COPD patients is important as most patients experience varied degrees of suffering toward the end-of-life. The purpose of this scoping review is to map out key concepts, main sources, and types of evidence available in the area of research on EOLC with multiple interventions for people with COPD.
methodsThis scoping review will be conducted following the latest Joanna Briggs Institute (JBI) guidelines. In addition, this review process will adhere to the preferred reporting items for systematic reviews and meta-analysis extension for scoping reviews (PRISMA-ScR). The initial simple search concepts will be set out as "chronic obstructive pulmonary disease" and "end-of-life care". Based on the eligibility criteria, Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, CINAHL Ultimate, Embase, and Google Scholar databases will be searched, and all quantitative and qualitative studies of the after-year publication of each electronic database will be included. This process of literature selection will be carried out independently by each researcher. The results will be summarised in a narrative synthesis approach and the gaps and potential biases of the evidence identified by comparing the adopted articles for EOLC with multiple interventions for people with COPD. DISCUSSION: This scoping review will outline in detail the evidence and the gaps from primary studies that have been gathered from the qualitative and quantitative literature based on all eligibility criteria. Therefore, the results of this review will contribute to a new field of systematic reviews. Furthermore, providing an outline of an EOLC for COPD in this study may improve the practice of healthcare professionals in this area. Ethical approval and consent are not required as no human participants were involved in this study. SYSTEMATIC REVIEW REGISTRATION: This research has been registered in the Open Science Framework (OSF) ( https://osf.io/upd4a ).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.